Product Information
METOPROLOL SUCC ER 50 MG TAB is a generic product labeled by Legacy Pharmaceutical Packaging, LLC, priced at $0.0515 per EA under NDC 68645047854. Its NADAC has been published 660 times since Feb 12, 2014.
FDA first approved this application on Aug 1, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Metoprolol succinate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Legacy Pharmaceutical Packaging, LLCNDC
68645047854
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA090617FDA Approved
8/1/2012
TE Code
AB
On Market Since
9/10/2012
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 50 MG TAB has been published 660 times since Feb 12, 2014, and over the history we have for it it has declined 86.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0515 per EA |
|---|---|
| All-time high | $0.3674 (Feb 12, 2014) |
| All-time low | $0.0515 (Sep 23, 2026) |
| 52-week high | $0.0655 |
| 52-week low | $0.0515 |
| Median price | $0.1247 |
| Average price | $0.1581 |
| Largest weekly change | -32.0% (Apr 17, 2024) |
| Weeks tracked | 660 |
| Tracking since | Feb 12, 2014 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Legacy Pharmaceutical Packaging, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 50 MG TAB, manufactured by Legacy Pharmaceutical Packaging, LLC, is $0.0515 per EA (NDC 68645047854), effective Sep 30, 2026.
How has the price of METOPROLOL SUCC ER 50 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 50 MG TAB has declined 86.0%. It has been tracked across 660 weekly CMS publications since Feb 12, 2014.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 50 MG TAB?
Since Feb 12, 2014, the NADAC for METOPROLOL SUCC ER 50 MG TAB has ranged from a low of $0.0515 (Sep 23, 2026) to a high of $0.3674 (Feb 12, 2014), with a median of $0.1247 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 50 MG TAB?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL SUCC ER 50 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METOPROLOL SUCC ER 50 MG TAB?
METOPROLOL SUCC ER 50 MG TAB (NDC 68645047854) is labeled by Legacy Pharmaceutical Packaging, LLC, and CMS classifies it as a generic product.